Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04851717 · ClinicalTrials.gov registry record · Phase 2
Investigation of Remimazolam in Children Undergoing Sedation for Medical Procedures
A Phase 2 study of Pediatric ALL, sponsored by Acacia Pharma.
- Active
- Registry status
- Phase 2
- Development phase
- 100
- Enrollment target
- 8
- Study locations
NCT04851717: Active Phase 2 study of Pediatric ALL, sponsored by Acacia Pharma.
NCT04851717 is a Phase 2 study of Pediatric ALL that is active but no longer recruiting, run by Acacia Pharma. The registered enrollment target is 100 participants, below the 1,643-participant average among 21 other Pediatric ALL trials with a reported enrollment target (94% lower). The trial reports 8 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04851717, a Phase 2 study of Pediatric ALL, is active but no longer recruiting, sponsored by Acacia Pharma.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 2
- Development phase
- 100 participants
- Enrollment target
- 8
- Study locations
Study Summary
To assess the efficacy of intravenous remimazolam in inducing and maintaining suitable sedation levels for paediatric patients undergoing diagnostic and/or therapeutic procedures
Primary Outcome
Success of the procedure defined as: Completion of the procedure AND no requirement for rescue sedative medication AND no requirement for more than the permitted bolus or infusion regimen
Conditions Studied
Interventions
- DRUG Remimazolam
Study Locations (8)
California
- Stanford University - Palo Alto
- University of California Davis Children's Hospital - Sacramento
Other
- Rigshospitalet - Copenhagen
- Odense Universitetshospital - Odense
Massachusetts
- Boston Children's Hospital - Boston
Minnesota
- University of Minnesota Masonic Children's Hospital - Minneapolis
Pennsylvania
- University of Pittsburgh Medical Center - Children's Hospital of Pittsburgh - Pittsburgh
Texas
- Texas Children's Hospital - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2021-11-15 |
| Est. Completion | 2027-10 |
| Phase | Phase 2 |
What the registry record for NCT04851717 still lists
NCT04851717 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,643-participant average among 21 other Pediatric ALL trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Pediatric ALL appearing as the primary indexed condition, and to 1 intervention - of which Remimazolam is the first listed.
NCT04851717 lists 8 locations in 6 states (California, Other, Massachusetts).
Frequently Asked Questions
What is clinical trial NCT04851717 about?
NCT04851717 is a clinical study titled "Investigation of Remimazolam in Children Undergoing Sedation for Medical Procedures". To assess the efficacy of intravenous remimazolam in inducing and maintaining suitable sedation levels for paediatric patients undergoing diagnostic and/or therapeutic procedures
What is the current status of trial NCT04851717?
This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 100 participants. The study started on 2021-11-15. Estimated completion is 2027-10.
What conditions does trial NCT04851717 study?
This clinical trial studies the following conditions: Pediatric ALL.
What interventions are being tested in trial NCT04851717?
The interventions under investigation include: Remimazolam (DRUG).
Who is sponsoring clinical trial NCT04851717?
This trial is sponsored by Acacia Pharma, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04851717 being conducted?
This trial has 8 study locations across California, Massachusetts, Minnesota, Pennsylvania, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pediatric ALL
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04851717's enrollment target sits among peer trials
100 10th of 21 higher than 12 of 21 other Pediatric ALL trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pediatric ALL trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Multiphase Optimization Strategy (MOST) for Treating Pediatric Post-traumatic Stress Disorder (PTSD)
RECRUITING · NA
-
PRotein Optimization With eXercise to Improve MUscle Mass and Functional outcomeS
RECRUITING · NA
-
Study of CD19-directed Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia
RECRUITING · Phase 1
-
Using Augmented Reality to Promote Physical Activity in Children With Cerebral Palsy
RECRUITING · NA
-
Feasibility/Acceptability of Attentional-Control Training in Survivors
RECRUITING · NA
-
Pharmacokinetics of Drugs Administered to Children
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI